LLY hits a historic $1T valuation as booming GLP-1 sales from Mounjaro and Zepbound drive growth and expand momentum across ...

Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, driven not only by outstanding earnings and a notable margin increase, but ...

Eli Lilly and Novo Nordisk are collaborating with Waltz Health to launch direct-to-employer access for obesity management medications. Waltz Health gave no information on the prices of GLP-1 drugs ...

INDIANAPOLIS, Oct. 30, 2024 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced its financial results for the third quarter of 2024. "Lilly had another strong growth quarter in Q3, with total ...

Woodline Partners LP, managed by Michael Rockefeller, recently executed a significant transaction involving Eli Lilly And ...

Morgan Stanley raised the firm’s price target on Eli Lilly (LLY) to $1,290 from $1,171 and keeps an Overweight rating on the ...

(Reuters) - U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately, months after former CFO Anat Ashkenazi stepped ...

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...

INDIANAPOLIS, Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO) and member ...

Three months after announcing that EVP and CFO Anat Ashkenazi would be leaving for another opportunity, Eli Lilly and Company has named a replacement. The pharma giant promoted Lucas Montarce to lead ...

Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access ...

Eli Lilly and Co. on Monday elevated a company insider to chief financial officer, succeeding Anat Ashkenazi, who left three months ago to join Google and Alphabet. Lucas Montarce, who has been with ...